Cargando…

Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

BACKGROUND: The autoantibody profile of seropositive rheumatoid arthritis (RA) is very diverse and consists of various isotypes and antibodies to multiple post-translational modifications. It is yet unknown whether this varying breadth of the autoantibody profile is associated with treatment outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Moel, Emma C., Derksen, Veerle F. A. M., Stoeken, Gerrie, Trouw, Leendert A., Bang, Holger, Goekoop, Robbert J., Speyer, Irene, Huizinga, Tom W. J., Allaart, Cornelia F., Toes, René E. M., van der Woude, Diane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828136/ https://www.ncbi.nlm.nih.gov/pubmed/29482627 http://dx.doi.org/10.1186/s13075-018-1520-4

Ejemplares similares

In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response
por: de Moel, Emma C., et al.
Publicado: (2019)

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations
por: de Moel, Emma C., et al.
Publicado: (2023)

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
por: de Moel, Emma C., et al.
Publicado: (2019)

The role of autoantibodies in the pathophysiology of rheumatoid arthritis
por: Derksen, V. F. A. M., et al.
Publicado: (2017)

In rheumatoid arthritis patients, total IgA1 and IgA2 levels are elevated: implications for the mucosal origin hypothesis
por: Derksen, Veerle F A M, et al.
Publicado: (2022)

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load
por: Reijm, Sanne, et al.
Publicado: (2021)

Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
por: Amkreutz, Josephine A. M. P., et al.
Publicado: (2021)

The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA
por: Suwannalai, Parawee, et al.
Publicado: (2011)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

A polymorphism in the IL-10 promoter affects autoantibody production and subsequent joint destruction in rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

A Candidate Gene Approach Identifies the TRAF1/C5 Region as a Risk Factor for Rheumatoid Arthritis
por: Kurreeman, Fina A. S, et al.
Publicado: (2007)

Correction: A Candidate Gene Approach Identifies the TRAF1/C5 Region as a Risk Factor for Rheumatoid Arthritis
por: Kurreeman, Fina A. S, et al.
Publicado: (2007)

Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study
por: van Wesemael, Tineke J., et al.
Publicado: (2016)

Autoantibodies to GPI are predominantly present in extra-articular complications of human rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

Association of the 6q23 region with the rate of joint destruction in rheumatoid arthritis
por: Scherer, Hans Ulrich, et al.
Publicado: (2009)

Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis
por: Akdemir, Gülşah, et al.
Publicado: (2018)

Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)
por: Westra, Johanna, et al.
Publicado: (2020)

Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology
por: Volkov, Mikhail, et al.
Publicado: (2019)

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
por: Habets, Kim L.L., et al.
Publicado: (2015)

Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences
por: Mahler, Michael, et al.
Publicado: (2013)

Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity?
por: Bergstra, Sytske Anne, et al.
Publicado: (2020)

Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study
por: van Gaalen, FA, et al.
Publicado: (2003)

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the article by Regueiro et al.
por: van Dijk, Bastiaan T., et al.
Publicado: (2020)

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment
por: Heckert, Sascha L, et al.
Publicado: (2023)

Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study
por: Janssen, Koen M J, et al.
Publicado: (2015)

Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study
por: Akdemir, Gülşah, et al.
Publicado: (2016)

Response to ‘Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis’ – authors’ reply
por: Markusse, Iris M., et al.
Publicado: (2015)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example
por: Boeters, Debbie M., et al.
Publicado: (2018)

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association
por: van den Beukel, Michelle D, et al.
Publicado: (2023)

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
por: Monahan, Rory C, et al.
Publicado: (2022)

Autoimmune Responses in the Rheumatoid Synovium
por: Toes, Rene E. M, et al.
Publicado: (2009)

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage
por: Brink, Mikael, et al.
Publicado: (2015)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

The prevalence of ACPA is lower in rheumatoid arthritis patients with an older age of onset but the composition of the ACPA response appears identical
por: Boeters, Debbie M., et al.
Publicado: (2017)

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
por: Güler-Yüksel, Melek, et al.
Publicado: (2010)

Antibodies Specific for Carbamylated Proteins Precede the Onset of Clinical Symptoms in Mice with Collagen Induced Arthritis
por: Stoop, Jeroen N., et al.
Publicado: (2014)

Light chain skewing in autoantibodies and B-cell receptors of the citrullinated antigen-binding B-cell response in rheumatoid arthritis
por: Slot, Linda M., et al.
Publicado: (2021)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_cemvk2l3luo0ksfuj4vbbpjjh5